| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-06 02:39:25 UTC |
|---|
| Updated at | 2022-09-06 02:39:25 UTC |
|---|
| NP-MRD ID | NP0224326 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (2s,3r,4r,5s,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)-n-methyl-n-nitrosooxane-3-carbamimidic acid |
|---|
| Description | Streptozocin, also known as zanosar, belongs to the class of organic compounds known as hexoses. These are monosaccharides in which the sugar unit is a is a six-carbon containing moeity. Streptozocin is a drug which is used for the treatment of malignant neoplasms of pancreas (metastatic islet cell carcinoma). Streptozocin is an extremely weak basic (essentially neutral) compound (based on its pKa). (2s,3r,4r,5s,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)-n-methyl-n-nitrosooxane-3-carbamimidic acid is found in Apis cerana and Streptomyces alanosinicus. (2s,3r,4r,5s,6r)-2,4,5-trihydroxy-6-(hydroxymethyl)-n-methyl-n-nitrosooxane-3-carbamimidic acid was first documented in 1959 (PMID: 13841501). Streptozocin is formally rated as a possible carcinogen (by IARC 2B) and is also a potentially toxic compound (PMID: 4170654) (PMID: 7926307) (PMID: 9421374). |
|---|
| Structure | CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O InChI=1S/C8H15N3O7/c1-11(10-17)8(16)9-4-6(14)5(13)3(2-12)18-7(4)15/h3-7,12-15H,2H2,1H3,(H,9,16)/t3-,4-,5-,6-,7+/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 2-Deoxy-2-(((methylnitrosoamino)carbonyl)amino)-D-glucopyranose | ChEBI | | 2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose | ChEBI | | Estreptozocina | ChEBI | | N-D-Glucosyl-(2)-n'-nitrosomethylharnstoff | ChEBI | | N-D-Glucosyl-(2)-n'-nitrosomethylurea | ChEBI | | Streptozocine | ChEBI | | Streptozocinium | ChEBI | | Streptozocinum | ChEBI | | Streptozotocin | ChEBI | | Zanosar | ChEBI | | Streptozotocine | HMDB | | Teva brand OF streptozocin | HMDB | | Streptozocin teva brand | HMDB | | 2-Deoxy-2-((methylnitrosoamino)carbonyl)amino-D-glucose | HMDB |
|
|---|
| Chemical Formula | C8H15N3O7 |
|---|
| Average Mass | 265.2206 Da |
|---|
| Monoisotopic Mass | 265.09100 Da |
|---|
| IUPAC Name | 3-methyl-3-nitroso-1-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea |
|---|
| Traditional Name | streptozocin |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O |
|---|
| InChI Identifier | InChI=1S/C8H15N3O7/c1-11(10-17)8(16)9-4-6(14)5(13)3(2-12)18-7(4)15/h3-7,12-15H,2H2,1H3,(H,9,16)/t3-,4-,5-,6-,7+/m1/s1 |
|---|
| InChI Key | ZSJLQEPLLKMAKR-GKHCUFPYSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| Not Available | | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as hexoses. These are monosaccharides in which the sugar unit is a is a six-carbon containing moeity. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Carbohydrates and carbohydrate conjugates |
|---|
| Direct Parent | Hexoses |
|---|
| Alternative Parents | |
|---|
| Substituents | - Hexose monosaccharide
- N-methylnitrosourea
- Nitrosourea
- Oxane
- Nitrosamide
- Semicarbazide
- Organic n-nitroso compound
- Hemiacetal
- Carbonic acid derivative
- Secondary alcohol
- Organic nitroso compound
- Oxacycle
- Polyol
- Organoheterocyclic compound
- Organonitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic nitrogen compound
- Carbonyl group
- Primary alcohol
- Alcohol
- Aliphatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aliphatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Mansford KR, Opie L: Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan. Lancet. 1968 Mar 30;1(7544):670-1. doi: 10.1016/s0140-6736(68)92103-x. [PubMed:4170654 ]
- Schnedl WJ, Ferber S, Johnson JH, Newgard CB: STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes. 1994 Nov;43(11):1326-33. doi: 10.2337/diab.43.11.1326. [PubMed:7926307 ]
- Wang Z, Gleichmann H: GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes. 1998 Jan;47(1):50-6. doi: 10.2337/diab.47.1.50. [PubMed:9421374 ]
- VAVRA JJ, DEBOER C, DIETZ A, HANKA LJ, SOKOLSKI WT: Streptozotocin, a new antibacterial antibiotic. Antibiot Annu. 1959-1960;7:230-5. [PubMed:13841501 ]
- LOTUS database [Link]
|
|---|